TGFB1 and Alzheimer disease: Along this line, the ability of carnosine to modulate the activity of immune cells such as macrophages and microglia [36,49,75,76], including the enhancement of their antioxidant machinery [49] as well as the increased production of anti-inflammatory molecules such as TGF-β1 [36], could be highly relevant for drug development in AD.